MarginsXMarginsX
Home › Markets › Health Care › LGVN

Longeveron Inc. (LGVN)

LGVN trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$2.14
-14.06% on the day
Market cap
$7.2M
Nano cap
Revenue · 2025
$1.2M
-49.9% on 2024
Net income · 2025
-$22.7M
-1893.6% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1721484/000119312526110664/0001193125-26-110664-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerLGVN on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2021
SEC CIK0001721484
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials · 2025

LineValue
Revenue$1.2M
Net income-$22.7M
Operating income-$23.3M
Net margin-1893.6%
Operating margin-1942.2%
Revenue growth-49.9%
Cash$4.7M
Total assets$10.3M
P/E (computed)Net income was not positive
P/S (computed)6.0×

Warning signs

Cash runway
4.8 months
$7.2M cash at September 30, 2026
Share count, 1 year
No year-earlier count
Going-concern doubt
Yes
10-Q filed November 12, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"As a result, there is substantial doubt about the Company's ability to continue as a going concern. 2."
10-Q 2026-11-12
Cash and burn$7.2M cash; operating cash flow -$4.5M a quarter.Report 2026-09-30
Shares outstanding138,405 (2026-11-10).Cover page 2026-11-10
Reverse splits, 3 years2; latest 1-for-10 on 2026-08-27Source 2026-08-27
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 months1 (8-K item 3.01)8-K 2026-03-25
AuditorCBIZ CPAs P.C., Hartford, Connecticut, United States; changed auditors 1 time in 24 months8-K 4.01 2025-03-14
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30
Market cap checkThe listing's market cap implies 3,373,340 shares at the 2026-11-13 price; the latest SEC cover count is 138,405 as of 2026-11-10. One of the two share counts is stale.Nasdaq screener and SEC cover page

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$115K-$6.1M-$2.7M$7.2MNo debt tags$1.2M10-Q 2026-11-12
Q2 2026
2026-06-30
$287K-$6.1M-$5.7M$10.1MNo debt tags$1.2M10-Q 2026-08-12
Q1 2026
2026-03-31
$398K-$4.7M-$4.4M$15.8MNo debt tags$1.2M10-Q 2026-05-13
Q4 2025
2025-12-31
$365K-$5.4M-$5.3M$4.7MNo debt tags$1.2M10-K 2026-03-17
Q3 2025
2025-09-30
$137K-$7.2M-$5.1M$9.2MNo debt tags$1.4M10-Q 2026-11-12
Q2 2025
2025-06-30
$316K-$5.0M-$3.6M$10.3MNo debt tags$2.1M10-Q 2026-08-12
Q1 2025
2025-03-31
$381K-$5.0M-$4.7M$14.3MNo debt tags$2.2M10-Q 2026-05-13
Q4 2024
2024-12-31
$603K-$4.1M-$3.4M$19.2MNo debt tags$2.4M10-K 2026-03-17

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
PROSPECTUS
424B32026-04-17
Latest annual report10-K2026-03-17
Latest quarterly / interim10-Q2026-11-12
Latest current report
CURRENT REPORT
8-K2026-11-12
Latest proxy
DEFINITIVE ADDITIONAL MATERIALS
DEFA14A2026-05-20

Source: SEC EDGAR submissions feed, 536 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+37.6%
1 month+15.8%
3 months-64.3%
Year to date-50.8%
1 year-63.9%
From 52-week high-78.5%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
IMRNImmuron Limited$0.8996+2.23%$7.3M
CURXCuranex Pharmaceuticals Inc$4.63-0.11%$7.3M
GTBPGT Biopharma Inc.$3.54-1.81%$7.3M
UPCUniverse Pharmaceuticals Inc.$1.48-1.99%$7.4M
XCURExicure Inc.$1.07-0.93%$7.0M
MBRXMoleculin Biotech Inc.$7.14-9.28%$7.6M
TPSTTempest Therapeutics Inc.$0.3418-10.50%$6.8M
SNGXSoligenix Inc.$0.2882-10.22%$6.7M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier